Menopoz ve Hormon Replasman Tedavisine Bağlı Orbital Hemodinamik Değişikliklerin Renkli Doppler Ultrasonografi ile İncelenmesi

Alp, Mehmet Numan; Aksay, Sevinç; Soydinç, Perihan; Ziraman, İpek; Kural, Gülcan
September 2007
Retina-Vitreus/Journal of Retina-Vitreous;Sep2007, Vol. 15 Issue 3, p193
Academic Journal
Purpose: To investigate the effect of menopause and hormone replacement therapy (HRT) on ocular blood flow. Materials and Methods: Colour Doppler ultrasonography (CDU) was used to determine peak systolic (PSV) and end diastolic (EDV) flow velocities and the resistivity index (RI) in the ophthalmic (OA) and the central retinal (CRA) arteries in 31 postmenopausal women who had never received HRT (mean age 50.6±6.1 years), 40 postmenopausal women receiving HRT (mean age 56.6±7.5 years), and 18 premenopausal women as controls (mean age 32.2±10.4 years). Twenty-five postmenopausal women who had never received HRT were re-evaluated by CDU, 6 months after the initiation of HRT. Results: Mean age and duration of menopause of postmenopausal women without HRT were significantly lower than those of postmenopausal women with HRT (p=0.005 and p=0.047, respectively). PSV (p<0.001, for both groups) and EDV (p=0.015 and p=0.002, respectively) in the CRA were significantly higher in postmenopausal women without and with HRT as compared to premenopausal women. RI in the CRA of postmenopausal women without HRT was significantly higher than that of control subjects (p=0.005). Six months after the initiation of HRT, EDV (p=0.019) and RI (p=0.010) in the CRA in 25 postmenopausal women who had never received HRT previously were found to be significantly increased and decreased, respectively. Although, PSV (p<0.001 and p=0.001, respectively) and EDV (p<0.001 and p=0.008 respectively) in the CRA were significantly higher in postmenopausal women with HRT and those who received HRT only for six months as compared to premenopausal women, RI in the CRA was not statistically different. Being independent from hormonal state, there was a positive correlation between age and each of PSV, EDV, and RI in the CRA (p=0.018, r=0.309; p=0.047, r=0.262, and p=0.045, r=0.265, respectively). Conclusion: Age related changes in blood flow parameters of the CRA were enhanced by menopause. HRT may play a role in the prevention of alterations in blood flow parameters of the CRA, which are related to aging and menopause, probably by causing a vasodilation and decreasing distal vascular resistance in the CRA. Since this effect on blood flow is not permanent and decreases with age and duration of menopause, HRT must be considered as a therapy that delays the occurrence of age and/or menopause related alterations in ocular blood flow.


Related Articles

  • Hormone replacement therapy: where are we now? Rees, Margaret; Marsden, Jo // Journal of the British Menopause Society;2002, Vol. 8 Issue 4, p128 

    The article presents information on various studies related to the hormone replacement therapy (HRT) concerning breast cancer in women. Observational studies show that women who take HRT believed to alter risk. Other studies show that HRT improves the menopausal symptoms and reduces the...

  • News and views. Stevenson, John C.; Rees, Margaret // Journal of the British Menopause Society;2004, Vol. 10 Issue 1, p6 

    The article presents information on the suggestions of the Chairman of the Committee on Safety of Medicines (CSM) about the use of hormone replacement therapy (HRT) in Great Britain. The CSM states that the risk-benefit ratio for HRT is favorable in the treatment of menopausal symptoms. The CSM...

  • Premenstrual symptoms with hormone replacement therapy. Hockey, Jo; Panay, Nick // Journal of the British Menopause Society;2004, Vol. 10 Issue 1, p38 

    The article presents information on a 52-year-old woman who has been referred to a specialist menopause clinic because of premenstrual-like symptoms with several forms of hormone replacement therapy. Bone mineral density shows osteoporosis in the femoral neck and osteopenia in her lumber spine....

  • Managing the menopause: BMS Council Consensus statement on HRT. Pitkin, Joan // Journal of the British Menopause Society;2004, Vol. 10 Issue 1, p33 

    The British Menopause Society Council aims to help health professionals to inform and advise women about the menopause. The oestrogen plus progestogen arm of the Women's Health Initiative was stopped in July 2002. This guidance regarding hormone replacement therapy (HRT) use responds to the...

  • Use of Hormone Replacement Therapy Among Danish Nurses at Increased Risk of Osteoporosis. Hundrup, Yrsa Andersen; Henrik Thoning; Rasmussen, Niels Kristian; Obel, Erik Bernhard; Philip, John // International Journal of Behavioral Medicine;Sep2003, Vol. 10 Issue 3, p269 

    Observational studies and recent randomized trials have shown that postmenopausal hormone replacement therapy (HRT) may reduce the risk of osteoporotic fractures by about 30 to 40%. In this study we used a log linear graphical model to determine whether women with a known increased risk of...

  • No long-term benefit shown for bones after HRT. Yates, J.; Barrett-Connor, E.; Barlas, S.; Chen, Y. T.; Miller, P. D.; Siris, E. S. // BMJ: British Medical Journal (International Edition);7/3/2004, Vol. 329 Issue 7456, preceding p1 

    Presents an abstract of a medical study to evaluate whether hormone replacement therapy continues to provide protection from hip fractures after the treatment is stopped. Report on the national osteoporosis risk assessment study for postmenopausal women; Conclusion that women taking short term...

  • Knowledge, Perceptions and Information about Hormone Therapy (HT) among Menopausal Women: A Systematic Review and Meta-Synthesis. MinFang Tao; YinCheng Teng; HongFang Shao; Ping Wu; Mills, Edward J. // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    Background: The use of hormone therapy (HT) by menopausal women has declined since the Women's Health Initiative randomized trial (WHI) in 2002 demonstrated important harms associated with long-term use. However, how this information has influenced women's knowledge and attitudes is uncertain....

  • Transdermal Menopausal Hormones May Be Most Effective. Finkel, Jon // Life Extension;Aug2010, Vol. 16 Issue 8, p15 

    The article discusses research which was conducted by the Division of Reproductive Endocrinology and Infertility at the Warren Alpert School of Brown University and which found that when the transdermal menopausal hormones estrogen and and testosterone are administered properly to patients the...

  • Research Update.  // CMAJ: Canadian Medical Association Journal;10/20/98, Vol. 159 Issue 8, p914 

    Reports on news and information in the field of medicine. Study that found hormone replacement therapy with estrogen plus progestin is ineffective against the risk of heart attack; The risk that alcohol poses to women who are trying to conceive; Lack of prevention by the spermicide nonoxynol 9...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics